Pharmaceutical Technology Department

Recent Research Published in Local and International Conferences and Journals for the Year

2020 - 2021

# Publisher  Author Title
1 A uthorea . DOI 10.22541/au.160862664.48679739/v1 Amr Y. Zakaria , Rania Labib , Sameh A. Abdelshafi3, Asmaa Salama , Omnia Hassanain , Hoda Rabia , Enas Elnadi ABCC2 (rs717620), and ABCC3 (rs4793665) affect high dose methotrexate toxicity, and outcome in children with osteosarcoma

2021 – 2022

# Publisher  Author Title
1 Journal of Clinical Pharmacy and Therapeutics 2022 Mar; 47(3):306-312. doi : 10.1111/jcpt.13556. El- Haggar SM, Hegazy SK, M Abd-Elsalam S, Bahaa MM.  Open-label pilot study of ethosuximide as adjunctive therapy for relieving abdominal pain related to Irritable Bowel Syndrome
2 Journal of Translational Medicine . 2022 Nov 26; 20(1):544. doi : 10.1186/s12967-022-03759-z. Abd El-Fattah EE , Amr Y. Zakaria Targeting HSP47 HSP70: promising therapeutic approaches in liver fibrosis management.
3 Clinical S Chizophrenia & Related Psychoses. 2022; 16:S1, Doi:10.3371/CSRP.ZMSS.022822. Mennatallah O. Zaki , Saad Shawki El- Sherifi , Ali Ahmed Abou Elmaaty , Amr Y. Zakaria , Abdelrheem M. Zidan , Abdulrahman M. Mahmoud, Omar Sh. Ali , Hosam A. Ashour , Hazem M. Abo -ghotma , Maryam M. Abdelhakim , Nada F. Ahmed , Hussieny E. Abdelazim , Khaled Ashraf , Ahmed R. Atya , Ranya A. Elsady , Galal S. Mehrez , Marwa A. Abdel- Dayem Evaluation of β-Amyloids and Tau Protein Biomarkers for Alzheimer's Disease in Serum of Alzheimer Patients

2022 - 2023

# Publisher  Author Title
1 Biomedicine & Pharmacotherapy . 2022 Jan; 145:112399. doi:10.1016/j.biopha.2021.112399. El- Haggar SM, Hegazy SK, Abd-Elsalam SM, Bahaa MM.  Pentoxifylline , a nonselective phosphodiesterase inhibitor, in adjunctive therapy in patients with irritable bowel syndrome treated with mebeverine
2 International Immunopharmacology 2022 Aug; 109:108889. doi:10.1016/j.intimp.2022.108889. Abd El-Fattah EE, Amr Y. Zakaria. Metformin modulates immune fitness in hepatocellular carcinoma: Molecular and cellular approach
3 European Review for Medical and Pharmacological Sciences. May 2022; 26(9):3132-3137. doi : 10.26355/eurrev_202205_28730.  Shawky D, Salamah AM, Abd-Elsalam SM, Habba E, Elnaggar MH, Elsawy AA, Baiomy N , Bahaa MM , Gamal RM. Nitazoxanide -based therapeutic regimen as a novel treatment for Helicobacter pylori infection in children and adolescents: a randomized trial
4 European review for medical and pharmacological sciences. 2023 Feb; 27(4):1512-1521. doi : 10.26355/eurrev_202302_31392.  El- Haggar SM, Hegazy SK, Mustafa W, Khrieba MO.  Possible immunomodulatory effects of tocilizumab in patients with refractory status epilepticus
5 International Journal of Health Sciences , no. IV, Apr. 18. 2022, p. 1383-1400, doi : 10.53730/ijhs.v6nS4.6194 . Mona Abd Elrafea Abdo , Osama Mohamed Ibrahim, Sahar Mohamed El- Haggar , Salwa Elmorsy El-Sayed Clinical study evaluating β-blockers use and fracture risk in patients with primary osteoporosis Running title
Scroll to Top